Estrogen decreases TNF gene expression by blocking JNK activity and the resulting production of c-Jun and JunD

Journal of Clinical Investigation

Volumn 104, Issue 4, 1999, Pages 503-513

  Srivastava, Sunil ^a   Weitzmann, M Neale ^a   Cenci, Simone ^a   Ross, F Patrick ^a   Adler, Stuart ^a   Pacifici, Roberto ^a  

^a BARNES JEWISH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BONE ATROPHY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; ENZYME BINDING; ENZYME INHIBITION; GENE EXPRESSION REGULATION; GENE REPRESSION; HORMONE ACTION; HUMAN; HUMAN CELL; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0032694582     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI7094     Document Type: Article

References (67)

1. Manolagas, S.C., and Jilka, R.L. 1995. Bone marrow, cytokines, and bone remodeling. N. Engl. J. Med. 332:305-311.
2. Gowen, M., Wood, D.D., Ihrie, E.J., McGuire, M.K.B., and Russell, R.G.G. 1983. An interleukin-1-like factor stimulates bone resorption in vitro. Nature. 306:378-380.
3. Horowitz, M. 1993. Cytokines and estrogen in bone: anti-osteoporotic effects. Science. 260:626-627.
4. Dinarello, C.A. 1991. Interleukin-1 and interleukin-1 antagonism. Blood. 77:1627-1652.
5. Dexter, T.M., Allen, T.D., and Lajyha, L.G. 1977. Conditions controlling the proliferation of hematopoietic cells in vitro. J. Cell. Physiol. 91:335-344.
6. Dexter, T.M., et al. 1990. Stromal cells in haemopoiesis. In Molecular control of haemopoiesis. G. Bock andJ. Marsh, editors. John Wiley & Sons Ltd. West Sussex, United Kingdom. 86-95.
7. Lacey, D.L., et al. 1998. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 93:165-176.
8. Quinn, J.M., Elliott, J., Gillespie, M.T., and Martin, T.J. 1998. A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro. Endocrinology. 139:4424-4427.
9. Suda, T., Takahashi, N., and Martin, T.J. 1992. Modulation of osteoclast differentiation. Endocr. Rev. 13:66-80.
10. Yoshida, H.S., et al. 1990. The murine mutation osteopetrosis is in the coding region of macrophage colony stimulating factor gene. Nature. 345:442-444.
11. Kimble, R., Bain, S., and Pacifici, R. 1997. The functional block of TNF but not of IL-6 prevents bone loss in ovariectomized mice. J. Bone Miner. Res. 12:935-941.
12. Ammann, P., et al. 1997. Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrogen deficiency. J. Clin. Invest. 99:1699-1703.
13. Pacifici, R., et al. 1991. Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells. Proc. Natl. Acad. Sci. USA. 88:5134-5138.
14. Pacifici, R., et al. 1989. Ovarian steroid treatment blocks a post-menopausal increase in blood monocyte interleukin 1 release. Proc. Natl. Acad. Sci. USA. 86:2398-2402.
15. Ralston, S.H. 1994. Analysis of gene expression in human bone biopsies by polymerase chain reaction: evidence for enhanced cytokine expression in postmenopausal osteoporosis. J. Bone Miner. Res. 9:883-890.
16. Kimble, R.B., Srivastava, S., Ross, F.P., Matayoshi, A., and Pacifici, R. 1996. Estrogen deficiency increases the ability of stromal cells to support osteoclastogenesis via an IL-1 and TNF mediated stimulation of M-CSF production. J. Biol. Chem. 271:28890-28897.
17. Ralston, S.H., Russell, R.G.G., and Gowen, M. 1990. Estrogen inhibits release of tumor necrosis factor from peripheral blood mononuclear cells in postmenopausal women. J. Bone Miner. Res. 5:983-988.
18. Shanker, G., Sorci-Thomas, M., and Adams, M.R. 1994. Estrogen modulaces the expression of tumor necrosis factor alpha mRNA in phorbol ester-stimulated human monocytic THP-1 cells. Lympbokine Cytokine Res. 13:377-382.
19. Sung, S.S., Bjorndahl, J.M., Wang, C.Y., Kao, H.T., and Fu, S.M. 1988. Production of tumor necrosis factor/cachectin by human T cell lines and peripheral blood T lymphocytes stimulated by phorbol myristate acetate and anti-CD3 antibody. J. Exp. Med. 167:937-953.
20. Yao, J., Mackman, N., Edgington, T.S., and Fan, S.T. 1997. Lipopolysaccharide induction of the tumor necrosis factor-alpha promoter in human monocytic cells. Regulation by Egr-1, c-Jun, and NF-kappaB transcription factors. J. Biol. Chem. 272:17795-17801.
21. Philip, R., and Epstein, L.B. 1986. Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, γ-interferon and interleukin-1. Nature. 323:86-89.
22. Chaplin, D.D., and Hogqist, K. 1992. Interactions between TNF and interleukin-1. In Tumor necrosis factors: the molecules and their emerging role in medicine. B. Beutler, editor. Raven Press. New York, NY. 197-220.
23. Dinarello, C.A. 1990. The parhophysiology of the pro-inflammatory cytokines. Biotherapy. 2:189-191.
24. Brenner, D.A., O'Hara, M., Angel, P., Chojkier, M., and Karin, M. 1989. Prolonged activation of jun and collagenase genes by tumour necrosis factor-alpha. Nature. 337:661-663.
25. Angel, P., and Karin, M. 1991. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta. 1072:129-157.
26. Foletta, V.C., Segal, D.H., and Cohen, D.R. 1998. Transcriptional regulation in the immune system: all roads lead to AP-1. J. Leukoc. Biol. 63:139-152.
27. Rhoades, K.L., Golub, S.H., and Economou, J.S. 1992. The regulation of the human tumor necrosis factor alpha promoter region in macrophage, T cell, and B cell lines. J. Biol. Chem. 267:22102-22107.
28. Beutler, B., and Brown, T. 1991. A CAT reporter construct allows ultra-sensitive estimation of TNF synthesis, and suggests that the TNF-gene has been silenced in non-macrophage cell lines. J. Clin. Invest. 87:1336-1344.
29. Han, J., Brown, T., and Beutler, B. 1990. Endotoxin-responsive sequences control cachectin/tumor necrosis factor biosynthesis at the translational level. J. Exp. Med. 171:465-475.
30. Hemsley, A., Arnheim, N., Toney, M.D., Cortopassi, G., and Galas, D.J. 1989. A simple method for site-directed mutagenesis using the polymerase chain reaction. Nucleic Acids Res. 17:6545-6551.
31. Rifas, L., et al. 1995. Production of interleukin-6 in human osteoblasts and human bone marrow stromal cells: evidence that induction by interleukin-1 and tumor necrosis factor-α is not regulated by ovarian steroids. Endocrinology. 136:4056-4067.
32. Tora, L., et al. 1989. The cloned human oestrogen receptor contains a mutation which alters its hormone binding properties. EMBO J. 8:1981-1986.
33. Meyers, C.Y., Lutfi, H.G., and Adler, S. 1997. Transcriptional regulation of estrogen-responsive genes by non-steroidal estrogens: doisynolic and allenolic acids. J. Steroid Biochem. Mol. Biol. 62:477-489.
34. Sambrook, J., Fritsch, E.F., and Maniatis, T. 1989. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press. Cold Spring Harbor, NY. 16.60.
35. Godambe, S.A., Chaplin, D.D., Takora, T., Read, L.M., and Bellone, C.J. 1995. A novel cis-acting element for lipopolysaccharide-induced transcription of the murine interleukin-1 β gene. Mol. Cell. Biol. 15:112-119.
36. Hall, C.V. Jacob, P.E., Ringold, G.M., and Lee, F. 1983. Expression and regulation of Escherichia coli Lac Z fusion in mammalian cells. J. Mol. Appl. Genet. 2:101-109.
37. Kitazawa, R., Kimble, R.B., Vannice, J.L., Kung, V.T., and Pacifici, R. 1994. Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice. J. Clin. Invest. 94:2397-2406.
38. Lu, B., et al. 1998. Estrogen receptor-beta mRNA variants in human and murine tissues. Mol. Cell. Endocrinol. 138:199-203.
39. Chaplin, D.D., et al. 1983. Molecular map of the murine S region. Proc. Natl. Acad. Sci. USA. 80:6947-6951.
40. Abu-Amer, Y., Ross, F.P., Edwards, J., and Teitelbaum, S.L. 1997. Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor. J. Clin Invest. 100:1557-1565.
41. Srivastava, S., et al. 1998. Estrogen blocks M-CSF gene expression and osteoclast formation by regulating CKII-induced phosphorylation of Egr-1 and its interaction with Sp-1. J. Clin. Invest. 102:1850-1859.
42. Jain, N., et al. 1996. Casein kinase II associates with Egr-1 and acts as a negative modulator of its DNA binding and transcription activities in NIH 3T3 cells. J. Biol. Chem. 271:13530-13536.
43. Towbin, H., Staehelin, T., and Gordon, J. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA. 76:4350-4354.
44. Hibi, M., Lin, A., Smeal, T., Minden, A., and Karin, M. 1993 Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev. 7:2135-2148.
45. Chan, E.D., Winston, B.W., Jarpe, M.B., Wynes, M.W., and Riches, D.W. 1997. Preferential activation of the p46 isoform of JNK/SAPK in mouse macrophages by TNF alpha. Proc. Natl. Acad. Sci. USA. 94:13169-13174.
46. Reinhard, C., Shamoon, B., Shyamala, V., and Williams, L.T. 1997. Tumor necrosis factor alpha-induced activation of c-jun N-terminal kinase is mediated by TRAF2. EMBO J. 16:1080-1092.
47. Beutler, B. 1992. Tumor necrosis factors: the molecules and their emerging role in medicine. Raven Press. New York, NY. 485-577.
48. Webb, P., Lopez, G.N., Uht, R.M., and Kusher, P.J. 1995. Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens. Mol. Endocrinol. 9:443-456.
49. Wei, P., Inamdar, N., and Vedeckis, W.V. 1998. Transrepression of c-jun gene expression by the glucocorricoid receptor requires both AP-1 sites in the c-jun promoter. Mol. Endocrinol. 12:1322-1333.
50. Kuiper, G.G., Enmark, E., Pelto-Huikko, M., Nilsson, S., and Gustafsson, J.A. 1996. Cloning of a novel receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. USA, 93:5925-5930.
51. Couse, J.F., Lindzey, J., Grandien, K., Gustafsson, J.A., and Korach, K.S. 1997. Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse. Endocrinology. 138:4613-4621.
52. Paech, K., etal. 1997. Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science. 277:1508-1510.
53. Shakhov, A.N., Collart, M.A., Vassalli, P., Nedospasov, S.A., and Jongeneel, C.V. 1990. kB enhancers are involved in liposaccharide-mediated transcriptional activation of the TNF α gene in primary macrophages. J. Exp. Med. 171:35-47.
54. Muegge, K., and Durum, S. 1990. Cytokines and transcription factors [review]. Cytokine. 2:1-8.
55. Stein, B., and Yang, M.X. 1995. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa-B and C/EBP-BETA. Mol. Cell. Biol. 15:4971-4979.
56. Minden, A., and Karin, M. 1997. Regulation and function of the JNK subgroup of MAP kinases. Biochim. Biophys. Acta. 1333:F85-F104.
57. Ip, Y.T., and Davis, R.J. 1998. Signal transduction by the c-Jun N-terminal kinase (JNK): from inflammation to development. Curr. Opin. Cell Biol. 10:205-219.
58. Westwick, J.K., Weitzel, C. Minden, A., Karin, M., and Brenner, D.A. 1994. Tumor necrosis factor alpha stimulates AP-1 activity through prolonged activation of the c-Jun kinase. J. Biol. Chem. 269:26396-26401.
59. Schmitt, M., et al. 1995. Positive and negative effects of nuclear receptors on transcription activation by AP-1 of the human choline acetyltransferase proximal promoter. J. Neurosci. Res. 40:152-164.
60. Umayahara, Y., et al. 1994. Estrogen regulation of the insulin-like growth factor I gene transcription involves an AP-1 enhancer. J. Biol. Chem. 269:16433-16442.
61. Liu, Y., Gorospe, M., Yang, C., and Holbrook, N.J. 1995. Role of mirogen-activated protein kinase phosphatase during the cellular response to genotoxic stress. Inhibition of c-Jun N-terminal kinase activity and AP-1-dependent gene activation. J. Biol. Chem. 270:8377-8380.
62. Hunter, T., and Karin, M., 1992. The regulation of transcription by phosphorylation. Cell. 70:375-387.
63. van Dam, H., et al. 1993. Heterodimer formation of cJun and ATF-2 is responsible for induction of c-jun by the 243 amino acid adenovirus E1A protein. EMBO J. 12:479-487.
64. Bradbeer, J.N., Stroup, S.J., Hoffman, J.C., and Gowen, M. 1996. An orally active inhibitor of cytokine synthesis prevents bone loss in the ovariectomized rat. J. Bone Min. Res. 11(Suppl. 1):S125. (Abstr.)
65. Gupta, S., et al. 1996. Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J. 15:2760-2770.
66. Whitmarsh, A.J., and Davis, R.J. 1996. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways, J. Mol. Med. 74:589-607.
67. Pacifici, R. 1996. Estrogen, cytokines and pathogenesis of post-menopausal osteoporosis. J. Bone Miner. Res. 11:1043-1051.